UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus–Associated, Clinical N2 Oropharyngeal Cancer

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (3), p.512-522

2016

Volltextzugriff (PDF)

Split-Course Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Single-Institution Experience of 144 Patients

Journal of thoracic oncology, 2011-06, Vol.6 (6), p.1079-1086

2011

Volltextzugriff (PDF)

The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

BMC cancer, 2018-03, Vol.18 (1), p.310-310, Article 310

2018

Volltextzugriff (PDF)

Theoretical and Practical Implications of Treating Cachexia in Advanced Lung Cancer Patients

Cancers, 2019-10, Vol.11 (11), p.1619

2019

Volltextzugriff (PDF)

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Lung cancer (Amsterdam, Netherlands), 2023-12, Vol.186, p.107423-107423, Article 107423

2023

Volltextzugriff (PDF)

Weight Gain in Advanced Non–Small-Cell Lung Cancer Patients During Treatment With Split-Course Concurrent Chemoradiotherapy Is Associated With Superior Survival

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (4), p.985-991

2011

Volltextzugriff (PDF)

Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy

Cancers, 2021-03, Vol.13 (6), p.1426

2021

Volltextzugriff (PDF)

Prevalence and Predictors of Neoadjuvant Therapy for Stage IIIA Non-Small Cell Lung Cancer in the National Cancer Database: Importance of Socioeconomic Status and Treating Institution

International journal of radiation oncology, biology, physics, 2014-06, Vol.89 (2), p.303-312

2014

Volltextzugriff (PDF)

Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls

Therapeutic advances in medical oncology, 2012-03, Vol.4 (2), p.51-60

2012

Volltextzugriff (PDF)

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer

Cancers, 2022-05, Vol.14 (10), p.2355

2022

Volltextzugriff (PDF)

Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis

International journal of radiation oncology, biology, physics, 2015-06, Vol.92 (2), p.307-316

2015

Volltextzugriff (PDF)

P2.41 (also presented as PD1.06): Pembrolizumab vs Docetaxel for Previously Treated NSCLC (KEYNOTE-010): Archival vs New Tumor Samples for PD-L1 Assessment

Journal of thoracic oncology, 2016-10, Vol.11 (10), p.S242-S243

2016

Volltextzugriff (PDF)

Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung

Oncoscience, 2014-08, Vol.1 (8), p.522-528

2014

Volltextzugriff (PDF)

Prognostic Significance of Weight Gain During Definitive Chemoradiotherapy for Locally Advanced Non–Small-Cell Lung Cancer

Clinical lung cancer, 2013-07, Vol.14 (4), p.370-375

2013

Volltextzugriff (PDF)

Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1393-1399

2018

Volltextzugriff (PDF)

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

The Lancet (British edition), 2019-01, Vol.393 (10167), p.156-167

2019

Volltextzugriff (PDF)

RNA sequencing to characterize pathways in EGFR-mutated non-small cell lung cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21019-e21019

2023

Volltextzugriff (PDF)

Clinical outcomes in patients with radioiodine refractory thyroid carcinoma treated with dose-reduced lenvatinib

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18104-e18104

2023

Volltextzugriff (PDF)

Utility of Insulin-like Growth Factor Receptor-1 Expression in Gefitinib-Treated Patients with Non-small Cell Lung Cancer

Anticancer research, 2012-05, Vol.32 (5), p.1705-1710

2012

Volltextzugriff (PDF)

Gender and weight change, skeletal muscle index(SMI) change, and survival in advanced non-small cell lung cancer(NSCLC) patients(pts.) receiving platinum chemotherapy

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e24080-e24080

2022

Volltextzugriff (PDF)

Research Highlights: Immunotherapy to overcome lung tumor cell-induced escape from immunosurveillance

Immunotherapy, 2010-11, Vol.2 (6), p.757-760

2010

Volltextzugriff (PDF)

Clinical and laboratory parameters associated with rapid progression in advanced NSCLC patients treated with second or third-line single agent immune checkpoint inhibitors (ICIs)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21087-e21087

2022

Volltextzugriff (PDF)

Abstract 1621: Comprehensive profiling of immune regulatory molecules in baseline sera from advanced stage NSCLC patients receiving anti-PD-1 and anti-PD-L1 immunotherapy: A prognostic potential

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1621-1621

2021

Volltextzugriff (PDF)

Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer

Proceedings of the National Academy of Sciences - PNAS, 2020-01, Vol.117 (2), p.1119-1128

2020

Volltextzugriff (PDF)

Sexual dysfunction in women with lung cancer: Updates from the SHAWL study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9071-9071

2023

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(55)
Tagungsberichte
(1)

Sprache

Englisch
(56)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(35)
Oncology
(31)
Humans
(28)
Female
(21)
Male
(19)
Aged
(18)
Middle Aged
(16)
Lung Neoplasms - Drug Therapy
(11)
Lung Neoplasms - Pathology
(11)
Neoplasm Staging
(11)
Carcinoma, Non-Small-Cell Lung - Pathology
(10)
Lung Cancer
(10)
Patients
(10)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(9)
Carcinoma, Non-Small-Cell Lung - Mortality
(9)
Chemotherapy
(9)
Lung Neoplasms - Mortality
(9)
Tumors
(9)
Chemoradiotherapy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus–Associated, Clinical N2 Oropharyngeal Cancer

Split-Course Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Single-Institution Experience of 144 Patients

The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

Theoretical and Practical Implications of Treating Cachexia in Advanced Lung Cancer Patients

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Weight Gain in Advanced Non–Small-Cell Lung Cancer Patients During Treatment With Split-Course Concurrent Chemoradiotherapy Is Associated With Superior Survival

Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy

Prevalence and Predictors of Neoadjuvant Therapy for Stage IIIA Non-Small Cell Lung Cancer in the National Cancer Database: Importance of Socioeconomic Status and Treating Institution

Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer

Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis

P2.41 (also presented as PD1.06): Pembrolizumab vs Docetaxel for Previously Treated NSCLC (KEYNOTE-010): Archival vs New Tumor Samples for PD-L1 Assessment

Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung

Prognostic Significance of Weight Gain During Definitive Chemoradiotherapy for Locally Advanced Non–Small-Cell Lung Cancer

Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

RNA sequencing to characterize pathways in EGFR-mutated non-small cell lung cancer

Clinical outcomes in patients with radioiodine refractory thyroid carcinoma treated with dose-reduced lenvatinib

Utility of Insulin-like Growth Factor Receptor-1 Expression in Gefitinib-Treated Patients with Non-small Cell Lung Cancer

Gender and weight change, skeletal muscle index(SMI) change, and survival in advanced non-small cell lung cancer(NSCLC) patients(pts.) receiving platinum chemotherapy

Research Highlights: Immunotherapy to overcome lung tumor cell-induced escape from immunosurveillance

Clinical and laboratory parameters associated with rapid progression in advanced NSCLC patients treated with second or third-line single agent immune checkpoint inhibitors (ICIs)

Abstract 1621: Comprehensive profiling of immune regulatory molecules in baseline sera from advanced stage NSCLC patients receiving anti-PD-1 and anti-PD-L1 immunotherapy: A prognostic potential

Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer

Sexual dysfunction in women with lung cancer: Updates from the SHAWL study

Suchergebnisse filtern